Home » Topics » Regulatory » Patents

Patents
RSS

RPR describes NMDA/glycine-site antagonists

May 3, 1996

Maxi-K channel modulators from Bayer

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

Teijin reports vitamin D3 derivatives for osteoporosis

May 3, 1996

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III
BioWorld
Days after Pfizer Inc. pulled the plug on its oral GLP-1 candidate danuglipron, Eli Lilly and Co. aired positive top-line data from the phase III trial called...
Many US tariffs paused, pharma warned, EU put on notice
BioWorld
The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...